Nutlin-3a and its derivatives play pivotal roles in inhibiting the growth of hematological malignancies, glioblastoma, and acute myelocytic leukemia cells because their structure is similar to that of p53 and allows competitive binding of MDM2 to p53.165. Here, TP53 is linked to acute myeloid leukemia.